BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 1360266)

  • 1. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype.
    Drach D; Zhao S; Drach J; Mahadevia R; Gattringer C; Huber H; Andreeff M
    Blood; 1992 Dec; 80(11):2729-34. PubMed ID: 1360266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-glycoprotein expression and function in circulating blood cells from normal volunteers.
    Klimecki WT; Futscher BW; Grogan TM; Dalton WS
    Blood; 1994 May; 83(9):2451-8. PubMed ID: 7513198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric assessment of human MIC2 expression in bone marrow, thymus, and peripheral blood.
    Dworzak MN; Fritsch G; Buchinger P; Fleischer C; Printz D; Zellner A; Schöllhammer A; Steiner G; Ambros PF; Gadner H
    Blood; 1994 Jan; 83(2):415-25. PubMed ID: 7506950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry.
    Bender JG; Unverzagt KL; Walker DE; Lee W; Van Epps DE; Smith DH; Stewart CC; To LB
    Blood; 1991 Jun; 77(12):2591-6. PubMed ID: 1710512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma.
    Pilarski LM; Belch AR
    Blood; 1994 Feb; 83(3):724-36. PubMed ID: 7507731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The heparin binding PECAM-1 adhesion molecule is expressed by CD34+ hematopoietic precursor cells with early myeloid and B-lymphoid cell phenotypes.
    Watt SM; Williamson J; Genevier H; Fawcett J; Simmons DL; Hatzfeld A; Nesbitt SA; Coombe DR
    Blood; 1993 Nov; 82(9):2649-63. PubMed ID: 7693043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of MDR1 by normal bone marrow cells and its implication for leukemic hematopoiesis.
    Drach J; Zhao S; Drach D; Körbling M; Engel H; Andreeff M
    Leuk Lymphoma; 1995 Feb; 16(5-6):419-24. PubMed ID: 7540457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of multidrug resistance P-glycoprotein in myeloid progenitor cells of different phenotype: comparison between normal bone marrow cells and leukaemia cells.
    Takeshita A; Shinjo K; Ohnishi K; Ohno R
    Br J Haematol; 1996 Apr; 93(1):18-21. PubMed ID: 8611458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes.
    Chaudhary PM; Mechetner EB; Roninson IB
    Blood; 1992 Dec; 80(11):2735-9. PubMed ID: 1360267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of multidrug resistance gene mdr1 mRNA in a subset of normal bone marrow cells.
    Marie JP; Brophy NA; Ehsan MN; Aihara Y; Mohamed NA; Cornbleet J; Chao NJ; Sikic BI
    Br J Haematol; 1992 Jun; 81(2):145-52. PubMed ID: 1353683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay.
    Ludescher C; Hilbe W; Eisterer W; Preuss E; Huber C; Gotwald M; Hofmann J; Thaler J
    J Natl Cancer Inst; 1993 Nov; 85(21):1751-8. PubMed ID: 8105101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection.
    Ciudad J; Orfao A; Vidriales B; Macedo A; Martínez A; González M; López-Berges MC; Valverde B; San Miguel JF
    Haematologica; 1998 Dec; 83(12):1069-75. PubMed ID: 9949623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL.
    Lúcio P; Parreira A; van den Beemd MW; van Lochem EG; van Wering ER; Baars E; Porwit-MacDonald A; Bjorklund E; Gaipa G; Biondi A; Orfao A; Janossy G; van Dongen JJ; San Miguel JF
    Leukemia; 1999 Mar; 13(3):419-27. PubMed ID: 10086733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotype analysis of hematopoietic CD34+ cell populations derived from human umbilical cord blood using flow cytometry and cDNA-polymerase chain reaction.
    Thoma SJ; Lamping CP; Ziegler BL
    Blood; 1994 Apr; 83(8):2103-14. PubMed ID: 7512840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase.
    Rappold I; Ziegler BL; Köhler I; Marchetto S; Rosnet O; Birnbaum D; Simmons PJ; Zannettino AC; Hill B; Neu S; Knapp W; Alitalo R; Alitalo K; Ullrich A; Kanz L; Bühring HJ
    Blood; 1997 Jul; 90(1):111-25. PubMed ID: 9207445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No evidence of significant activity of the multidrug resistance gene product in primary human breast cancer.
    Hegewisch-Becker S; Staib F; Löning T; Pichlmeier U; Kröger N; Reymann A; Hossfeld DK
    Ann Oncol; 1998 Jan; 9(1):85-93. PubMed ID: 9541688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of MDR1 gene in acute leukemia cells: association with CD7+ acute myeloblastic leukemia/acute lymphoblastic leukemia.
    Miwa H; Kita K; Nishii K; Morita N; Takakura N; Ohishi K; Mahmud N; Kageyama S; Fukumoto M; Shirakawa S
    Blood; 1993 Dec; 82(11):3445-51. PubMed ID: 7694687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias.
    Gekeler V; Frese G; Noller A; Handgretinger R; Wilisch A; Schmidt H; Muller CP; Dopfer R; Klingebiel T; Diddens H
    Br J Cancer; 1992 Sep; 66(3):507-17. PubMed ID: 1355660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Flow cytometric detection of minimal residual disease in pre-cursor-B-acute lymphoblastic leukemia on the basis of phenotypic aberrancies on minor leukemic cell populations].
    Wu M; Sun XF; Xu ZM; Zhang XY; Li FR; Wang XG; Chen XL; Lin HQ; Wen HG; Sun X; Song TW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):557-62. PubMed ID: 16129033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of P glycoprotein activity on normal and leukemic CD34+ cells.
    Drenou B; Fardel O; Amiot L; Fauchet R
    Leuk Res; 1993 Dec; 17(12):1031-5. PubMed ID: 7504150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.